Document is current
Any future updates will be listed below
-
Authors
Li, Grace Xiuqing
Ma, Binyun
Zhang, Shaobing
Liu, Ren
Siddiqi, Imran N.
Sali, Akash
El-Khoueiry, Anthony
Gross, Mitchell
Salhia, Bodour
Sadeghi, Sarmad
Gill, Parkash S.
- License Information
-
More Information
Article History
Received: 1 June 2024
Revised: 31 October 2024
Accepted: 14 January 2025
First Online: 5 March 2025
Competing interests
: The authors declare no conflict of interest. PSG is a shareholder of the company developing sEphB4-albumin.
: Vertebrate murine studies were conducted under the animal welfare committee approved protocol- IACUC- 20421. All methods were performed in accordance with the relevant guidelines and regulations.
